A healthcare worker administers a third dose of the Pfizer-BioNTech Covid-19 vaccine at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.
Side effects from Covid booster shots are similar to those felt after the second dose and are more likely to affect younger people, Pfizer said in new data submitted to the Food and Drug Administration as it seeks approval to distribute booster shots across the U.S.
Pfizer's Phase 3 study of booster doses, which included a group of about 300 participants from 18 to 55 years old, found that 63.7% experienced fatigue after getting their boosters, 48.4% had headaches, and 39.1% felt muscle pain. The majority of reactions to the booster were mild or moderate in severity, the company said in a 52-page report released by the agency on Wednesday.
Pfizer previously evaluated side effects on 2,682 second-dose recipients ages 16 to 55 and found that 61.5% developed fatigue, 54% suffered headaches and 39.3% dealt with muscle pain. The study also tracked adverse events among 306 booster recipients, 44 of whom developed at least one unexpected side effect. The most common adverse event, swelling of the lymph nodes, appeared in 16 of the participants.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Top FDA vaccine regulators resist COVID booster shots, fear adverse reactions backfiringInternational scientists cautioned that 'significant' adverse reactions to booster shots could make people more hesitant about getting the COVID-19 vaccine.
Read more »
FDA Could Authorize COVID Vaccine for Ages 5-11 in OctoberThe timeline is based on the expectation that Pfizer will have enough data from clinical trials to request FDA emergency use authorization for the age group near the end of September.
Read more »
FDA experts oppose U.S. plan to give COVID-19 boosters to allIn a review, scientists conclude the vaccines are working well despite the extra-contagious delta variant, especially against severe disease.
Read more »
COVID-19 vaccine boosters not widely needed, top FDA and WHO scientists sayAdditional COVID-19 vaccine booster shots are not needed for the general population, leading scientists including two departing senior U.S. Food and Drug Administration officials and several from the World Health Organization (WHO) said in an article published in a medical journal on Monday.
Read more »
Who needs a Covid booster? FDA experts oppose plan to give extra dose to allIn a review, scientists conclude the vaccines are working well despite the extra-contagious delta variant, especially against severe disease.
Read more »
Two departing FDA leaders among scientists who say Covid-19 vaccines do not currently 'show a need for boosting'Two departing FDA leaders have joined an international group of scientists to say current evidence doesn't appear to show a need for boosters in most people
Read more »